Answers are grounded in this paper and cite their sources.
Nasopharyngeal carcinoma (NPC) is an aggressive and metastatic malignancy. Drug resistance remains a major barrier to its treatment. We analyzed transcriptome data related to paclitaxel (PTX) resistance in NPC using bioinformatic approaches. A protein-protein interaction (PPI) network was constructed to identify resistance-related core genes. Clinical progression-free survival (PFS) data and gene expression profiles from NPC patients were used to build a risk prediction model via LASSO-Cox regression analysis. Single-cell transcriptomic data (GSE150430) were examined to determine the cellular origin of the identified genes. Molecular docking was performed to evaluate the predicted interaction scores between paclitaxel and selected candidate proteins. A total of 216 PTX resistance-associated genes were identified. PPI network analysis showed that keratins were the main hub genes. LASSO-Cox regression identified eight prognostic genes (LAMB4, MEIS3, MMP15, CACNB3, KCNK9, HYAL1, P2RY2, and SLC1A4). Among these, LAMB4, MMP15, KCNK9, HYAL1, and P2RY2 were significantly associated with patient PFS. Single-cell analysis revealed that KRT6A, KRT16, KRT4, SPRR1B, JUP, CLCA2, SCEL, and PPL were expressed mainly in malignant cells. Molecular docking showed that KRT4, CLCA2, and JUP had relatively favorable predicted docking scores with paclitaxel under the applied computational protocol. KRT4, CLCA2, and JUP were predominantly expressed in malignant cells and showed relatively favorable predicted docking scores with paclitaxel. Together with the prognostic analysis, these findings prioritize KRT4, CLCA2, and JUP as candidate resistance-associated genes for future investigation. However, these results are hypothesis-generating and require validation in independent clinical cohorts and functional experiments.
No takes yet. Share an insight, caveat, or question.
Zeng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: